worth buying post Earnings results? OTCMKTS:FUJIY, NYSE:RPM, OTCMKTS:AGYTF, NASDAQ:ANGO

FUJIFILM (OTCMKTS:FUJIY) EARNINGS INFORMATION (OTCMKTS:FUJIY)

FUJIFILM last issued its quarterly earnings data on November 15th, 2020. The technology company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.62 by $0.33. FUJIFILM has generated $2.81 earnings per share over the last year and currently has a price-to-earnings ratio of 18.6. FUJIFILM has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, February 4th, 2021 based off prior year’s report dates.

HOW HAS FUJIFILM’S STOCK BEEN IMPACTED BY COVID-19? (OTCMKTS:FUJIY)

FUJIFILM’s stock was trading at $46.75 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, FUJIY stock has increased by 25.2% and is now trading at $58.54.

RPM INTERNATIONAL (NYSE:RPM) EARNINGS INFORMATION (NYSE:RPM)

RPM International last announced its quarterly earnings results on January 5th, 2021. The specialty chemicals company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.06. The firm had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.45 billion. Its quarterly revenue was up 6.0% compared to the same quarter last year. RPM International has generated $3.07 earnings per share over the last year and currently has a price-to-earnings ratio of 30.2. RPM International has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, April 14th, 2021 based off prior year’s report dates.

HOW HAS RPM INTERNATIONAL’S STOCK PRICE BEEN IMPACTED BY COVID-19? (NYSE:RPM)

RPM International’s stock was trading at $63.49 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RPM stock has increased by 38.6% and is now trading at $88.01.

(OTCMKTS:AGYTF)

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN ALLERGY THERAPEUTICS? (OTCMKTS:AGYTF)

Wall Street analysts have given Allergy Therapeutics a “N/A” rating, but there may be better short-term opportunities in the market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Allergy Therapeutics wasn’t one of them. MarketBeat thinks these five stocks may be even better buys.

ANGIODYNAMICS (NASDAQ:ANGO) EARNINGS INFORMATION (NASDAQ:ANGO)

AngioDynamics last posted its earnings data on January 6th, 2021. The medical instruments supplier reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.03. The business had revenue of $72.80 million for the quarter, compared to analyst estimates of $67.33 million. Its revenue was up 4.0% compared to the same quarter last year. AngioDynamics has generated $0.09 earnings per share over the last year. AngioDynamics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, April 6th, 2021 based off prior year’s report dates.

HOW HAS ANGIODYNAMICS’ STOCK BEEN IMPACTED BY CORONAVIRUS (COVID-19)? (NASDAQ:ANGO)

AngioDynamics’ stock was trading at $10.14 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ANGO stock has increased by 83.1% and is now trading at $18.5650.